BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 10907603)

  • 1. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
    Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
    Taş A; Cakir Gundogan F; Akgun H; Erdem U; Sobaci G
    Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual evoked potentials during hyperthermia.
    Saul RF; Hayat G; Selhorst JB
    J Neuroophthalmol; 1995 Jun; 15(2):70-8. PubMed ID: 7550932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of VEP components in optic neuritis.
    Andersson T; Sidén A
    Electromyogr Clin Neurophysiol; 1995 Mar; 35(2):77-85. PubMed ID: 7781577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a.
    Liscić RM; Brecelj J
    Croat Med J; 2004 Jun; 45(3):323-7. PubMed ID: 15185427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shift of temporal responsivity curve of pattern reversal visually evoked potentials to lower frequencies in patients after recovery from optic neuritis.
    Okuno T; Oku H; Sugasawa J; Utsumi T; Ikeda T
    Acta Ophthalmol; 2009 Nov; 87(7):780-3. PubMed ID: 18937806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis.
    Stefano E; Cupini LM; Rizzo P; Pierelli F; Rizzo PA
    Acta Neurol Belg; 1991; 91(1):20-8. PubMed ID: 2028736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
    Klistorner A; Graham S; Fraser C; Garrick R; Nguyen T; Paine M; O'Day J; Grigg J; Arvind H; Billson FA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4549-56. PubMed ID: 17898277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uhthoff's symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis.
    Scholl GB; Song HS; Wray SH
    Ann Neurol; 1991 Aug; 30(2):180-4. PubMed ID: 1654765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady state VER measurement of visual system latency in normal and multiple sclerosis patients.
    van Brocklin MD; Yolton RL
    J Am Optom Assoc; 1979 Feb; 50(2):203-7. PubMed ID: 458100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visual evoked potentials in reversal and motion-onset stimulation of visual fields in patients with retrobulbar neuritis].
    Kubová Z; Kuba M
    Cesk Oftalmol; 1993 Oct; 49(5):278-85. PubMed ID: 8221941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of visual evoked potentials in optic neuritis.
    Heinrichs IH; McLean DR
    Can J Neurol Sci; 1988 Nov; 15(4):394-6. PubMed ID: 3208223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in conduction velocity after optic neuritis measured with the multifocal VEP.
    Yang EB; Hood DC; Rodarte C; Zhang X; Odel JG; Behrens MM
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):692-8. PubMed ID: 17251467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation.
    Gundogan FC; Demirkaya S; Sobaci G
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visual evoked potentials: methodologic problems--variations of stimulus parameters].
    Diener HC; Zimmermann C
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Sep; 16(3):155-7. PubMed ID: 3933955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.